Objective: To determine the association between gaseous and fine particulate air pollution (PM(2.5)) and epilepsy in a general population sample.
Method: A daily time-series analyses tested the association between daily hospitalization for epilepsy in seven Chilean urban centers during the period 2001 and 2005. Results were adjusted for long term trends, day-of-the-week, and average humidex on the day of hospitalization and the day before.
Results: Pooled city estimates of relative risk (95% CI) of hospitalization for epilepsy associated with changes in pollutant concentrations equivalent to their interquartile range were: 1.098(1.045, 1.155) for carbon monoxide (CO); 1.100 (1.025, 1.181) for ozone O(3); 1.085 (1.03, 1.144) for sulfur dioxide (SO(2)); 1.108 (1.021, 1.204) for nitrogen dioxide (NO(2)); 1.083(1.038, 1.13) for particulate matter
Interpretation: Air pollution may be a risk factor for hospitalization for epilepsy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.envint.2010.03.008 | DOI Listing |
J Neurol Neurosurg Psychiatry
January 2025
National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark.
Background: We quantify the loss of working years for people with epilepsy compared with the general population and consider variation by aetiology, psychiatric comorbidity, sex and age.
Methods: This population-based cohort study included all individuals aged 18-65 years living in Denmark from 1995 to 2018. Using nationwide registers since 1977, we identified people with epilepsy and obtained information on the main source of income or employment for each year during follow-up from 1995 to 2020.
Gene
January 2025
Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150081, PR China. Electronic address:
Currently, the pathogenesis of epilepsy remains poorly understood. Although there is evidence indicating that iron death might play a significant role, its molecular immunological mechanisms are largely unknown. This study was designed to analyze and explore the molecular mechanisms and immunological characteristics of iron death-related genes in epilepsy.
View Article and Find Full Text PDFMicrob Pathog
January 2025
Van Yuzuncu Yıl University, Faculty of Medicine, Department of Parasitology, Van, Türkiye.
Neurocysticercosis (NCC) has been classified as a neglected tropical disease by the World Health Organization (WHO), with the condition being regarded as the most significant parasitic disease affecting the nervous system. Hence, the aim of this study was to conduct a review of previously published case reports on this topic in order to ascertain whether there is an increasing trend of NCC worldwide and evaluate the cases that have been presented. After a comprehensive search of the Web of Science Core Collection using the keywords "neurocysticercosis" and "case reports", studies were selected by applying inclusion criteria.
View Article and Find Full Text PDFPediatr Neurol
January 2025
Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China; Beijing Key Laboratory of Epilepsy, Beijing, China; Center of Epilepsy, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, China. Electronic address:
Background: Sturge-Weber syndrome (SWS) is a rare congenital neurocutaneous disorder, often complicated by epilepsy. Approximately 50% of patients with SWS with epilepsy develop drug-resistant seizures, leaving limited treatment options. Vagus nerve stimulation (VNS) is a known therapy for refractory epilepsy, modulating neural activity to reduce seizures.
View Article and Find Full Text PDFSeizure
January 2025
Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, PR China; Institute of Epilepsy, Shandong University, Jinan, Shandong, PR China. Electronic address:
Background: Post-stroke epilepsy (PSE) poses a significant challenge despite advances in stroke treatment. This study compares the efficacy of the novel anti-seizure medication (ASM) Perampanel with the classical ASM Oxcarbazepine in treating PSE.
Methods: This prospective randomized controlled trial recruited PSE patients from September 2022 to January 2024 across multiple hospitals.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!